Sustained activation of cardiac p38 mitogen activated protein kinase in the development of heart failure: Premature mortality is abolished by chronic p38 inhibition in rat model of cardiac hypertrophy and failure

被引：0
|
作者：
Behr, TM
Nerurkar, SS
Nelson, AH
Lee, JC
Sisko, J
Sackner-Bernstein, JD
Willette, RN
机构：
[1] SmithKline Beecham Pharmaceut, King Of Prussia, PA 19406 USA
[2] St Lukes Hosp, New York, NY USA
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1412
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [1] The case for inhibiting p38 mitogen-activated protein kinase in heart failure
    Arabacilar, Pelin
    Marber, Michael
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [2] p38 mitogen-activated protein kinase - A future for heart failure therapy?
    Kerkela, Risto
    Force, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (03) : 556 - 558
  • [3] Hypertensive end organ damage and premature mortality are p38 MAPK dependent in a rat model of cardiac hypertrophy and failure
    Behr, TM
    Nerurkar, SS
    Nelson, AH
    Woods, T
    Sulpizio, A
    Chandra, S
    Brooks, D
    Lee, JC
    Coatney, RW
    Angermann, CE
    Sackner-Bernstein, JD
    Sisko, J
    Adams, J
    Ohlstein, EH
    Willette, RN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 169A - 170A
  • [4] Role of p38 mitogen-activated protein kinase in cardiac remodelling
    Frantz, S.
    Behr, T.
    Hu, K.
    Fraccarollo, D.
    Strotmann, J.
    Goldberg, E.
    Ertl, G.
    Angermann, C. E.
    Bauersachs, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (02) : 130 - 135
  • [5] Inhibition of P38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure due to myocardial infarction
    Liu, YH
    Wang, DH
    Rhaleb, NE
    Yang, XP
    Xu, JA
    Yu, AL
    Rudolph, AE
    Carretero, OA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 180A - 180A
  • [6] Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction
    Behr, TM
    Nerurkar, SS
    Nelson, AH
    Coatney, RW
    Woods, TN
    Sulpizio, A
    Chandra, S
    Brooks, DP
    Kumar, S
    Lee, JC
    Ohlstein, EH
    Angermann, CE
    Adams, JL
    Sisko, J
    Sackner-Bernstein, JD
    Willette, RN
    CIRCULATION, 2001, 104 (11) : 1292 - 1298
  • [7] P38γ MITOGEN-ACTIVATED PROTEIN KINASE IS A MEDIATOR OF PATHOLOGICAL CARDIAC HYPERTOPHY
    Thomas, M.
    Uddin, S.
    Loonat, A.
    Marber, M.
    Clark, J.
    HEART, 2014, 100 : A3 - A4
  • [8] A role for p38α mitogen-activated protein kinase in embryonic cardiac differentiation
    Hernandez-Torres, Francisco
    Martinez-Fernandez, Sergio
    Zuluaga, Susana
    Nebreda, Angel
    Porras, Almudena
    Aranega, Amelia E.
    Navarro, Francisco
    FEBS LETTERS, 2008, 582 (07): : 1025 - 1031
  • [9] Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction
    Liu, YH
    Wang, DH
    Rhaleb, NE
    Yang, XP
    Xu, J
    Sankey, SS
    Rudolph, AE
    Carretero, OA
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (01) : 74 - 81
  • [10] Inhibition of p38 mitogen-activated protein kinase protects neonatal rat cardiac myocytes from ischemia
    Mackay, K
    Mochly-Rosen, D
    FASEB JOURNAL, 1998, 12 (04): : A73 - A73
12345